fluorexon has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dietrich, D; Hanafy, AS; Lamprecht, A | 1 |
| Berardi, F; Cantore, M; Capparelli, E; Colabufo, NA; Contino, M; Inglese, C; Leopoldo, M; Niso, M; Perrone, MG; Perrone, R | 1 |
2 other study(ies) available for fluorexon and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Capillaries; Endothelial Cells; Homeostasis; Mice; Perfusion; Probenecid | 2023 |
A benzopyrane derivative as a P-glycoprotein stimulator: a potential agent to decrease β-amyloid accumulation in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzopyrans; Biological Transport, Active; Brain; Cell Line; Dogs; Dose-Response Relationship, Drug; Fluoresceins; Fluorescent Dyes; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Multidrug Resistance-Associated Proteins; Neuroprotective Agents; Rhodamines | 2012 |